Retinal vessel diameter obtained by optical coherence tomography is spared in Parkinson’s disease
- 186 Downloads
To define the alterations in retinal vessel diameter in Parkinson’s disease (PD) by optical coherence tomography (OCT).
This is a case-control study including 41 eyes of 41 patients with diagnosis of PD and 35 eyes of 35 age- and sex-matched control subjects. All subjects underwent complete neurological and ophthalmological examinations before measurements. Retinal vessel diameters and peripapillary retinal nerve fiber layer (pRNFL) thicknesses were evaluated with spectral domain OCT (SD-OCT) with a circular scan centered at the optic disc. The diameters of the superior nasal and temporal arteries and veins, and inferior nasal and temporal arteries and veins were measured and then compared between the groups. Correlations with the duration of the disease, usage of levodopa, and pRNFL thicknesses between retinal vessel diameters were examined with Pearson and Spearman correlation analysis.
Average pRNFL thickness is significantly decreased in PD compared to age- and sex-matched controls (p < 0.05). At all measurement points, retinal artery diameter measurements were decreased in the PD group compared to controls, but the differences did not reach statistical significance. Diameters of the retinal veins also did not show any significant difference in the PD and control groups. Superior temporal artery diameter was significantly decreased in patients using levodopa compared to nonusers (p = 0.022). There were no statistically significant correlations between pRNFL thicknesses or disease duration with retinal vessel diameters in PD group.
Parkinson’s disease does not seem to have an impact on the retinal vessel diameters obtained by SD-OCT.
KeywordsOptical coherence tomography Parkinson’s disease Retina Retinal nerve fiber layer Retinal vessel diameter
The study was approved by the Erciyes University Clinical Research Ethics Committee (No: 2016/24, date: August 1, 2016).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest. We confirm that we had full access to all data and we took final responsibility for decision to submit.
- 3.Hatate J, Miwa K, Matsumoto M, Sasaki T, Yagita Y, Sakaguchi M, Kitagawa K, Mochizuki H (2016) Association between cerebral small vessel diseases and mild parkinsonian signs in the elderly with vascular risk factors. Parkinsonism Relat Disord 26:29–34. https://doi.org/10.1016/j.parkreldis.2016.02.011 CrossRefGoogle Scholar
- 4.Polo V, Satue M, Rodrigo MJ, Otin S, Alarcia R, Bambo MP, Fuertes MI, Larrosa JM, Pablo LE, Garcia-Martin E (2016) Visual dysfunction and its correlation with retinal changes in patients with Parkinson’s disease: an observational cross-sectional study. BMJ Open 6(5):e009658. https://doi.org/10.1136/bmjopen-2015-009658 CrossRefGoogle Scholar
- 10.Gonzalez-Lopez JJ, Rebolleda G, Leal M, Oblanca N, Munoz-Negrete FJ, Costa-Frossard L, Alvarez-Cermeno JC (2014) Comparative diagnostic accuracy of ganglion cell-inner plexiform and retinal nerve fiber layer thickness measures by Cirrus and Spectralis optical coherence tomography in relapsing-remitting multiple sclerosis. Biomed Res Int 2014:128517. https://doi.org/10.1155/2014/128517 CrossRefGoogle Scholar
- 14.Fernandez-Seara MA, Mengual E, Vidorreta M, Aznarez-Sanado M, Loayza FR, Villagra F, Irigoyen J, Pastor MA (2012) Cortical hypoperfusion in Parkinson’s disease assessed using arterial spin labeled perfusion MRI. Neuroimage 59(3):2743–2750. https://doi.org/10.1016/j.neuroimage.2011.10.033 CrossRefGoogle Scholar
- 18.Mendrinos E, Mangioris G, Papadopoulou DN, Donati G, Pournaras CJ (2013) Long-term results of the effect of intravitreal ranibizumab on the retinal arteriolar diameter in patients with neovascular age-related macular degeneration. Acta Ophthalmol 91(3):e184–190. https://doi.org/10.1111/aos.12008 CrossRefGoogle Scholar
- 19.Kumagai K, Tsujikawa A, Muraoka Y, Akagi-Kurashige Y, Murakami T, Miyamoto K, Yamada R, Yoshimura N (2014) Three-dimensional optical coherence tomography evaluation of vascular changes at arteriovenous crossings. Invest Ophthalmol Vis Sci 55(3):1867–1875. https://doi.org/10.1167/iovs.13-13303 CrossRefGoogle Scholar
- 20.van der Holst HM, van Uden IW, Tuladhar AM, de Laat KF, van Norden AG, Norris DG, van Dijk EJ, Esselink RA, Platel B, de Leeuw FE (2015) Cerebral small vessel disease and incident parkinsonism: the RUN DMC study. Neurology 85(18):1569–1577. https://doi.org/10.1212/WNL.0000000000002082 CrossRefGoogle Scholar